Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Do circulating testosterone levels decline with age and does irregular ovulation in the menopausal transition further lower ovarian steroid output?

Circulating testosterone falls with age in women, and anovulatory or irregular cycles during the menopausal transition further reduce ovarian steroid production in some cycles.

SupportedJune 19, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

In women, circulating testosterone levels generally decline with age, and irregular ovulation during the menopausal transition can further lower ovarian steroid output in some cycles.

laying out figure…
All 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a progressive decline in female androgens across midlife that accelerates through the menopausal transition and becomes more variable. Mechanistically, reduced follicle reserves and less efficient theca cell androgen production during anovulatory cycles, together with shifts in hypothalamic–pituitary signaling, explain the lower ovarian steroid output and resultant drop in circulating testosterone.

Verified conclusion

The hormonal landscape for women in their 40s undergoes significant shifts as both chronological aging and the transition toward menopause alter endocrine output. Research confirms that circulating testosterone levels and overall ovarian steroid production follow predictable, though complex, downward trajectories during this life stage.

Clinical and physiological evidence

Longitudinal data, including a 15-year study of 629 women, demonstrates that total testosterone and the free androgen index decline significantly starting as early as the fourth decade. This decline is largely linear through the menopausal transition, reaching a nadir around age 60.

  • Androgen Decline: Total testosterone levels drop as women move toward their final menstrual period (FMP), driven by a reduction in both ovarian and adrenal precursor production.
  • Impact of Cycle Variability: During the perimenopausal transition, the frequency of anovulatory cycles increases. These specific cycles are characterized by a marked reduction in ovarian steroid output compared to ovulatory cycles, as the absence of a dominant follicle limits the standard steroidogenic pathways.

Mechanistic explanations

The reduction in testosterone and other steroids is driven by several physiological changes:

  • Follicular Depletion: As the primordial follicle pool diminishes, the standard cycle-dependent surges in steroidogenesis become less frequent.
  • Theca Cell Dynamics: In ovulatory cycles, luteinizing hormone (LH) stimulates theca cells to produce androgens. In anovulatory cycles, despite elevated LH levels, the overall efficiency of this conversion pathway is compromised, leading to lower net ovarian output of testosterone and androstenedione.
  • HPT Axis Changes: The decline is further compounded by shifts in the hypothalamic-pituitary-gonadal axis, which regulates the pulsatile release of hormones necessary for maintaining androgen levels.

Bottom line

The claim is strongly supported: circulating testosterone levels decline with age, and the irregular, anovulatory cycles common in the menopausal transition further suppress ovarian steroid output. For a woman in her early 40s, these changes represent a transition from the relatively stable hormonal environment of early adulthood to a phase of increased variability and overall androgen decline.

References

  1. Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging. — pmc.ncbi.nlm.nih.gov ↗
  2. Aging and androgens: Physiology and clinical implications. — pmc.ncbi.nlm.nih.gov ↗
  3. Bioavailable Testosterone Linearly Declines Over A Wide Age Spectrum in Men and Women From The Baltimore Longitudinal Study of Aging. — pmc.ncbi.nlm.nih.gov ↗
  4. Adrenal androgens and the menopausal transition. — pmc.ncbi.nlm.nih.gov ↗
  5. Menopausal transition stage–specific changes in circulating adrenal androgens — pmc.ncbi.nlm.nih.gov ↗
  6. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease — pmc.ncbi.nlm.nih.gov ↗
  7. Steroid Hormone Secretion Over the Course of the Perimenopause: Findings From the Swiss Perimenopause Study — pmc.ncbi.nlm.nih.gov ↗
  8. Combined ovarian and adrenal vein catheterization to determine the site(s) of androgen overproduction in hirsute women. — academic.oup.com ↗
  9. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test. — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→